Skip to main content
Caplight Logo









Amissa Health

Amissa Health

Private
Charlotte, North CarolinaHealthcare & Life Scienceshttps://www.amissa.com/

Last Round

Pre Seed

Jun 25, 2026

Total Funding Raised

$505,000

Company Overview

Amissa Health is a digital health company that provides a platform for longitudinal monitoring by integrating consumer wearable sensor data and patient-reported symptom capture to support clinical care and research in menopause and Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Patient Engagement, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical decision supportpatient-reported outcomesfemtechwearable sensor datamenopause caredigital health platformlongitudinal symptom trackingclinical trial managementreal-world evidencevertical SaaShealth IoTbrain healthclinical workflow automationremote patient monitoringRPM

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amissa Health Comparables

Compare Amissa Health with similar companies based on industry and business-model similarity.

Amissa Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lisa Health
66%
Percy
62%
Elektra Health
62%

Amissa Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 25, 2026
GrantSep 28, 2024

Key People

Founding team and executive leadership

Jon Corkey ⌚️

Founder, Chief Strategy and Research Officer

Founding Team

Sam Smith

Co-Founder & CEO

Founding Team

Amissa Health Investors

Notable investors and investment history

Amissa Health investors
InvestorRounds
NIH RADxGrant
National Institute on AgingGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 19, 2025

    Grew 44% QoQ, from 9 to 13 employees.

  • Jun 6, 2025

    Grew 33% QoQ from 9 to 12 employees.

Amissa Health Filings

Explore SEC and related filing metadata, where available.

Amissa Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amissa Health's valuation, stock price, and market status.

Is Amissa Health a public or private company?

Amissa Health is a private company.

What is the current stock price of Amissa Health?

Amissa Health is a private company with no public stock price. No recent secondary market data is available.

How much is Amissa Health worth (valuation)?

Valuation information for Amissa Health is not publicly available.

Can I buy Amissa Health stock?

Amissa Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amissa Health's last funding round?

Amissa Health's most recent funding round was Pre Seed on June 25, 2026.

Who are the main investors in Amissa Health?

Key investors in Amissa Health include NIH RADx, National Institute on Aging.

Will Amissa Health IPO soon?

No public IPO plans have been announced for Amissa Health.

How can I track Amissa Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amissa Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCharlotte, North Carolina
Employee Range15
Year Founded2017
Last FundingJun 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?